We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current CVKD market cap is 27.62M. The company's latest EPS is USD -5.0381 and P/E is -3.15.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | ||||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -1.14M | -1.26M | -1.76M | -2.47M | -2.46M |
| Net Income | -1.04M | -1.14M | -1.66M | -2.39M | -2.41M |
| Year End 31 December 2023 | 2022 | 2023 |
|---|---|---|
| USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 |
| Operating Income | -2.7M | -7.63M |
| Net Income | -6.71M | -8.36M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | ||||
| Total Assets | 9.31M | 8.52M | 7.05M | 5.46M | 4.68M |
| Total Liabilities | 566k | 827k | 856k | 1.47M | 1.27M |
| Total Equity | 8.75M | 7.69M | 6.19M | 3.99M | 3.41M |
| Year End 31 December 2023 | 2022 | 2023 |
|---|---|---|
| USD (US$) | USD (US$) | |
| Total Assets | 778k | 8.52M |
| Total Liabilities | 6.33M | 827k |
| Total Equity | -5.55M | 7.69M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | ||||
| Operating | -2.84M | -3.53M | -1.84M | -3.37M | -5.57M |
| Investing | -3k | -3k | N/A | N/A | N/A |
| Financing | 11.92M | 11.9M | N/A | N/A | 1.53M |
| Year End 31 December 2023 | 2022 | 2023 |
|---|---|---|
| USD (US$) | USD (US$) | |
| Operating | -1.2M | -3.53M |
| Investing | -2k | -3k |
| Financing | 1.24M | 11.9M |
| Market Cap | 27.62M |
| Price to Earnings Ratio | -3.15 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 3.13 |
| Price to Book Ratio | 3.42 |
| Dividend Yield | - |
| Shares Outstanding | 1.66M |
| Average Volume (1 week) | 41.68k |
| Average Volume (1 Month) | 43.53k |
| 52 Week Change | 72.91% |
| 52 Week High | 22.9011 |
| 52 Week Low | 5.40 |
| Spread (Intraday) | 0.43 (2.54%) |
| Company Name | Cadrenal Therapeutics Inc |
| Address |
651 n broad st suite 201 middletown, delaware 19709 |
| Website | https://www.cadrenal.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
